
Concert Pharmaceuticals CNCE
Quarterly report 2022-Q3
added 11-07-2022
Concert Pharmaceuticals Historical Prices 2011-2026 | CNCE
Annual Historical Prices Concert Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 3.03 | 10.5 | 10.7 | 14.2 | 20.1 | 8.85 | 15.3 | 13.2 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.1 | 3.03 | 12 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M | ||
|
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | ||
|
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | ||
|
AbbVie
ABBV
|
226 | $ 210.4 | -0.34 % | $ 372 B | ||
|
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | ||
|
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | ||
|
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | ||
|
I-Mab
IMAB
|
0.68 | - | - | $ 866 M | ||
|
Genfit SA
GNFT
|
3.36 | - | 2.54 % | $ 160 B | ||
|
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | ||
|
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | ||
|
Aileron Therapeutics
ALRN
|
2.13 | - | 10.36 % | $ 9.8 M | ||
|
Aptinyx
APTX
|
0.14 | - | -39.0 % | $ 4.57 M | ||
|
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | ||
|
Arena Pharmaceuticals
ARNA
|
92.9 | - | -6.81 % | $ 3.04 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | ||
|
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | ||
|
Atreca
BCEL
|
1.27 | - | -11.76 % | $ 5.79 M | ||
|
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | ||
|
bluebird bio
BLUE
|
0.61 | - | - | $ 546 M | ||
|
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M | ||
|
Avid Bioservices
CDMO
|
6.7 | - | - | $ 789 M | ||
|
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
0.31 | - | -9.65 % | $ 45.9 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
16.4 | $ 12.84 | -8.02 % | $ 1.95 B | ||
|
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
311 | $ 320.76 | -2.25 % | $ 42 B | ||
|
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | ||
|
Cara Therapeutics
CARA
|
1 | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
26.9 | - | - | $ 3.74 B | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
0.89 | $ 1.08 | -1.06 % | $ 22.2 M | ||
|
Enochian Biosciences
ENOB
|
0.7 | - | - | $ 40.5 M | ||
|
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | ||
|
Equillium
EQ
|
2.06 | $ 1.99 | -3.4 % | $ 114 M | ||
|
Amgen
AMGN
|
369 | $ 351.45 | -0.49 % | $ 189 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
26.7 | $ 19.45 | -0.41 % | $ 909 M | ||
|
Amarin Corporation plc
AMRN
|
14 | $ 14.42 | -1.7 % | $ 5.98 B | ||
|
Bellerophon Therapeutics
BLPH
|
8.23 | - | -74.18 % | $ 955 K | ||
|
ANI Pharmaceuticals
ANIP
|
61.9 | $ 73.82 | -0.43 % | $ 1.43 B | ||
|
CRISPR Therapeutics AG
CRSP
|
48.8 | $ 46.45 | -2.31 % | $ 4.18 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
4.42 | $ 4.33 | -2.7 % | $ 830 M | ||
|
Allakos
ALLK
|
1.31 | - | - | $ 28.6 M | ||
|
Brickell Biotech
BBI
|
2.11 | - | -5.38 % | $ 6.06 M |